Continuous | | | |
Age (years) | 70.76 (10.68) | 68.62 (10.48) | 0.4047 |
Baseline IOP (mm Hg) | 26.05 (4.82) | 20.97 (2.85) | 0.0000 |
IOP (mm Hg) at 1 hour post-treatment | 25.23 (5.76) | 21.14 (4.82) | 0.0024 |
Total energy (mJ) | 44.95 (10.73) | 43.87 (10.83) | 0.6825 |
Categorical | | | |
Sex (F/M) | 18/25 | 12/17 | 0.968 |
Glaucoma type (OAG/others) | 29/14 | 17/12 | 0.445 |
Previous ALT (Y/N) | 12/31 | 7/22 | 0.722 |
Other surgery during study (Y/N) | 20/19 | 13/14 | 0.802 |
Hypertension (Y/N) | 5/34 | 9/20 | 0.066 |
Diabetes mellitus (Y/N) | 1/38 | 1/28 | 0.831 |
Myopia (Y/N) | 3/36 | 3/26 | 0.504 |
Family history of glaucoma (Y/N) | 9/30 | 2/27 | 0.073 |
TM pigmentation (grade 1–4)† | 1256 | 955 | 0.489 |
BCVA (median)‡ | 20/30 | 20/30 | 0.834 |